Latest
Recommended
Published: Wed, September 07, 2016
Economy | By Melissa Porter

EpiPen maker Mylan to be investigated for antitrust, AG says


A preliminary review conducted by Schneiderman's staff found that the company may have included anti-competitive terms into EpiPen sales contracts with several schools throughout the state.

New York's top prosecutor said he is launching an antitrust investigation into the maker of the EpiPen.

But their concern should be more about the daughter of another senator, Democrat Amy Klobuchar of Minnesota, who has a nut allergy and must have an EpiPen on hand.

The manufacturer has supplied more than 700,000 Epi-Pen auto-injectors to more than 65,000 schools since 2012.

The company has come under scrutiny in recent weeks after news surfaced that the price of a two-pack EpiPen has soared, rising from approximately $100 in 2009 to around $600 and more today, according to medical literature and various pharmacies nationwide.

Responding to outrage on raised prices for the EpiPen, Mylan announced that it would introduce a generic version for $300, while also continuing to sell the branded product.

Senate Democrats on Tuesday urged federal regulators to probe whether Mylan violated antitrust laws when it allegedly required schools to sign noncompete contracts.

The EpiPen4Schools program allows schools to get up to four auto-injectors for free, after which the schools receive a discounted price of $112.10.

Two Democratic congressmen are raising questions about whether Mylan NV, the company facing backlash for raising the price of its EpiPen device, overcharged the government's Medicaid program for the allergy treatment.

Tuesday's lawsuit was filed in the Court of Common Pleas for Hamilton County, Ohio, by Cincinnati resident Linda Bates, whose son requires an EpiPen.

Impax spokesman Mark Donohue declined to comment on whether the company would lower Adrenaclick's list price given the planned cheaper price of Mylan's generic injector.

Make it your business. In a statement from her campaign, Clinton said, "Since there is no apparent justification in this case, I am calling on Mylan to immediately reduce the price of EpiPens".

Like this: